Tox21_202335

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

29 API Suppliers, 14 USDMF, 4 CEP/COS, 2 JDMF, 15 NDC API, 14 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

94 Drugs in Development

94 Drugs in Development

INTERMEDIATES

2 API Suppliers

2 API Suppliers

FINISHED DOSAGE FORMULATIONS

167 FDF Dossiers, 66 FDA Orange Book, 42 Europe, 6 Canada, 28 Australia, 11 South Africa, 14 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;TOPICAL - 2%, SOLUTION;TOPICAL - 5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - 0.5%, CREAM;TOPICAL - 4%

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 9 DKSH, 1 Jai Radhe Sales, 1 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 5 Actylis, 10 BASF, 1 BioSpectra, 1 Clariant, 2 Corel Pharma Chem, 2 Finar, 6 Gangwal Chemicals, 7 Kerry, 2 Lubrizol Life Science Health, 3 Microlex e.U, 2 Nanjing Bold Chemical, 1 Pluviaendo, 4 Roquette, 9 Seppic, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

27 Topical, 22 Solubilizers, 15 Parenteral, 11 Film Formers & Plasticizers, 10 Emulsifying Agents, 9 Thickeners and Stabilizers, 9 Fillers, Diluents & Binders, 9 Coating Systems & Additives, 7 Surfactant & Foaming Agents, 7 Co-Processed Excipients, 5 Direct Compression, 4 Lubricants & Glidants, 3 Controlled & Modified Release, 2 Granulation, 2 Rheology Modifiers, 1 API Stability Enhancers